![Thomas Wei](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Wei
Technik-/Wissenschafts-/F&E-Leiter bei
AURINIA PHARMACEUTICALS INC.
Profil
Mr. Thomas Wei is a Chief Scientific Officer at Tang Capital Acquisition Corp., a Chief Scientific Officer at Aurinia Pharmaceuticals, Inc. and a Managing Director at Tang Capital Management LLC.
Mr. Wei was previously employed as a Chief Scientific Officer by Odonate Therapeutics, Inc., an Equity Analyst by Jefferies LLC, a Managing Director & Principal by U.S.
Bancorp Piper Jaffray Ventures, a Research Associate by Deutsche Bank Securities, Inc., an Analyst by Adams Harkness & Hill Investment Banking, and a Managing Director by Piper Jaffray & Co. (Broker).
He received his undergraduate degree from Harvard University and an MBA from the University of Oxford.
Aktive Positionen von Thomas Wei
| Unternehmen | Position | Beginn |
|---|---|---|
| AURINIA PHARMACEUTICALS INC. | Technik-/Wissenschafts-/F&E-Leiter | 21.03.2026 |
Tang Capital Management LLC
 Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Portfolio Manager-Aktien | 01.01.2015 |
Ehemalige bekannte Positionen von Thomas Wei
| Unternehmen | Position | Ende |
|---|---|---|
| ODONATE, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2021 |
U.S. Bancorp Piper Jaffray Ventures
 U.S. Bancorp Piper Jaffray Ventures Investment ManagersFinance Piper Jaffray Ventures focuses on emerging-growth companies in medical devices, healthcare services and technology. | Corporate Officer/Principal | 30.09.2009 |
Piper Sandler & Co. (Broker)
 Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 15.08.2009 |
Deutsche Bank Securities, Inc.
 Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | - |
Adams Harkness & Hill Investment Banking
 Adams Harkness & Hill Investment Banking Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Adams Harkness & Hill Investment Banking is a company based in Boston, MA. | Corporate Officer/Principal | 30.04.2000 |
Ausbildung von Thomas Wei
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
87
Beziehungen ersten Grades
10
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 10 |
|---|---|
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
Piper Sandler & Co. (Broker)
Piper Sandler & Co. (Broker) Investment Banks/BrokersFinance Provides brokerage services | Finance |
Tang Capital Management LLC
Tang Capital Management LLC Investment ManagersFinance Tang Capital focuses on investments in small-cap US companies in the life sciences sector. | Finance |
Jefferies LLC
 Jefferies LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adams Harkness & Hill Investment Banking
Adams Harkness & Hill Investment Banking Investment ManagersFinance Part of Canaccord Genuity Group, Inc., Adams Harkness & Hill Investment Banking is a company based in Boston, MA. | Finance |
U.S. Bancorp Piper Jaffray Ventures
U.S. Bancorp Piper Jaffray Ventures Investment ManagersFinance Piper Jaffray Ventures focuses on emerging-growth companies in medical devices, healthcare services and technology. | Finance |
Aurinia Pharmaceuticals, Inc.
 Aurinia Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company, which focuses on discovery and development of immunomodulating therapeutics | Health Technology |
Odonate, Inc.
 Odonate, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for cancer treatment | Health Technology |
